4//SEC Filing
SAXE JON S 4
Accession 0001415889-22-002290
CIK 0001411685other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:12 PM ET
Size
5.5 KB
Accession
0001415889-22-002290
Insider Transaction Report
Form 4
SAXE JON S
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-03-01+100,000→ 100,000 totalExercise: $1.37Exp: 2032-03-01→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, which vest in twelve equal monthly installments, beginning on the date of the grant.
Documents
Issuer
VistaGen Therapeutics, Inc.
CIK 0001411685
Entity typeother
Related Parties
1- filerCIK 0001114914
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 4:12 PM ET
- Size
- 5.5 KB